Since GLP-1 slows digestion and prolongs satiety, youll likely feel fuller during your eating window, helping you consume fewer calories
These results show that LipRSV has limited impact on VPA-induced neurochemical changes under the tested conditions
A Mayo Clinic study found postmenopausal women using hormone therapy alongside tirzepatide (a GLP-1/GIP dual agonist) experienced notably greater weight loss compared with those using tirzepatide without HRT
In fact, the FDAs official approval data for semaglutide explicitly states that the medication is intended as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management
Because of this, it is highly regarded for its cognitive benefits, supporting brain health and focus, in addition to providing metabolic advantages
However, remember the 28-day rule